FIELD: pharmacology.
SUBSTANCE: pharmaceutical preparation in the form of a solution for use in rheumatological diseases treatment contains a combination comprising sodium diclofenac or naproxen sodium, betamethasone sodium phosphate and hydroxy-cobalamin sulfate as active substances and benzyl alcohol, propylene glycol, sodium metabisulphite and water for injection as auxiliary components. A method for production of the preparation is described as well.
EFFECT: stable, effective formulation with analgesic, anti-inflammatory and antineurotic effects.
4 cl, 1 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SPASMOLYTIC COMPOSITION, METHOD TO OBTAIN SPASMOLYTIC COMPOSITION | 1997 |
|
RU2182016C2 |
| PHARMACEUTICAL COMBINATION CONTAINING 3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYLPROPYL)PHENOL AND NON-STEROID ANTI-INFLAMMATORY PREPARATION | 2007 |
|
RU2465263C2 |
| COMBINED PREPARATION FOR TREATING SKIN DISEASES | 2002 |
|
RU2223097C1 |
| DRUG FOR TREATING OSTEOARTHROSIS (VERSIONS) | 2013 |
|
RU2538218C2 |
| AGENT FOR TREATING DEGENERATIVE PROCESSES OF MUSCULOSKELETAL SYSTEM | 2024 |
|
RU2827071C1 |
| PHARMACEUTICAL COMPOSITION POSSESSING ANTI-INFLAMMATORY AND ANALGESIC EFFECT AND METHOD FOR ITS PREPARING | 2006 |
|
RU2309738C1 |
| COMBINED AGENT FOR TREATING ARTHROLOGICAL DISEASES | 2024 |
|
RU2827069C1 |
| PHARMACEUTICAL COMPOSITION POSSESSING ANTI-ALLERGIC AND ANTI-INFLAMMATORY EFFECT | 2004 |
|
RU2281102C2 |
| COMBINED ACTIVE COMPOSITION FOR TREATING LOCOMOTOR DISEASES | 2015 |
|
RU2582974C1 |
| PHARMACEUTICAL AGENT FOR ARTHRITIC DISEASES TREATMENT | 2020 |
|
RU2739747C1 |
